John W. Hubbard

3.7k total citations
152 papers, 2.9k citations indexed

About

John W. Hubbard is a scholar working on Pharmacology, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, John W. Hubbard has authored 152 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pharmacology, 33 papers in Pharmacology and 33 papers in Psychiatry and Mental health. Recurrent topics in John W. Hubbard's work include Pharmacogenetics and Drug Metabolism (27 papers), Analytical Chemistry and Chromatography (20 papers) and Drug Transport and Resistance Mechanisms (20 papers). John W. Hubbard is often cited by papers focused on Pharmacogenetics and Drug Metabolism (27 papers), Analytical Chemistry and Chromatography (20 papers) and Drug Transport and Resistance Mechanisms (20 papers). John W. Hubbard collaborates with scholars based in Canada, United States and Switzerland. John W. Hubbard's co-authors include K.K. Midha, Kamal K. Midha, E. D. Korchinski, Maureen J. Rawson, G. McKay, James E. Lawler, Nuggehally R. Srinivas, J.K. Cooper, E. M. Hawes and Declan Quinn and has published in prestigious journals such as Brain Research, Journal of Applied Physiology and Journal of Controlled Release.

In The Last Decade

John W. Hubbard

148 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John W. Hubbard Canada 29 935 460 458 418 409 152 2.9k
Stephen H. Curry United States 32 721 0.8× 288 0.6× 405 0.9× 319 0.8× 601 1.5× 130 3.3k
Sebastian Härtter Germany 33 1.0k 1.1× 532 1.2× 844 1.8× 709 1.7× 471 1.2× 81 3.8k
Sheila Dawling United Kingdom 31 538 0.6× 362 0.8× 523 1.1× 441 1.1× 605 1.5× 75 3.1k
Lars F. Gram Denmark 35 835 0.9× 457 1.0× 1.2k 2.6× 976 2.3× 361 0.9× 75 3.6k
P. L. Morselli Italy 40 1.3k 1.4× 824 1.8× 625 1.4× 425 1.0× 521 1.3× 138 4.4k
Marcia Divoll United States 34 807 0.9× 476 1.0× 618 1.3× 772 1.8× 183 0.4× 70 3.1k
D J Greenblatt United States 33 663 0.7× 699 1.5× 587 1.3× 1.0k 2.5× 336 0.8× 81 3.3k
Roberto Goméni Italy 33 538 0.6× 434 0.9× 718 1.6× 288 0.7× 582 1.4× 179 3.3k
Joseph C. Fleishaker United States 27 538 0.6× 288 0.6× 462 1.0× 381 0.9× 327 0.8× 85 2.1k
Iain M. McIntyre United States 35 383 0.4× 574 1.2× 580 1.3× 199 0.5× 304 0.7× 137 3.5k

Countries citing papers authored by John W. Hubbard

Since Specialization
Citations

This map shows the geographic impact of John W. Hubbard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John W. Hubbard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John W. Hubbard more than expected).

Fields of papers citing papers by John W. Hubbard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John W. Hubbard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John W. Hubbard. The network helps show where John W. Hubbard may publish in the future.

Co-authorship network of co-authors of John W. Hubbard

This figure shows the co-authorship network connecting the top 25 collaborators of John W. Hubbard. A scholar is included among the top collaborators of John W. Hubbard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John W. Hubbard. John W. Hubbard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gundersen, Linda, et al.. (2009). Towards a global data network for the geosciences. AGU Fall Meeting Abstracts. 2009. 1 indexed citations
2.
Midha, K.K., Maureen J. Rawson, & John W. Hubbard. (2005). The bioequivalence of highly variable drugs and drug products. International Journal of Clinical Pharmacology and Therapeutics. 43(10). 485–498. 60 indexed citations
3.
Midha, K.K., G. McKay, Maureen J. Rawson, E. D. Korchinski, & John W. Hubbard. (2001). Effects of Food on the Pharmacokinetics of Methylphenidate. Pharmaceutical Research. 18(8). 1185–1189. 35 indexed citations
4.
Hubbard, John W., et al.. (1997). Stereoselective and simultaneous measurement of cis- and trans-isomers of doxepin and N-desmethyldoxepin in plasma or urine by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 691(1). 131–138. 16 indexed citations
5.
Hubbard, John W., et al.. (1997). Stereoselectivein vivoandin vitrostudies on the metabolism of doxepin andN-desmethyldoxepin. Xenobiotica. 27(12). 1245–1258. 8 indexed citations
6.
Hadad, Salim, et al.. (1995). Evidence for the Lack of a Human Metabolic Isotope Effect of a Deuterium Analog of Fluphenazine. Pharmaceutical Research. 12(9). 1388–1390. 1 indexed citations
7.
Hubbard, John W., et al.. (1995). The Pharmacokinetics and Cardiovascular Pharmacodynamics of HP 749 (Besipirdine HCl) and Metabolite P86–7480 in the Conscious Monkey. The Journal of Clinical Pharmacology. 35(7). 688–696. 5 indexed citations
8.
Yeung, Pollen, John W. Hubbard, E. D. Korchinski, & K.K. Midha. (1993). Pharmacokinetics of chlorpromazine and key metabolites. European Journal of Clinical Pharmacology. 45(6). 563–569. 64 indexed citations
9.
Hubbard, John W.. (1991). My Chance: Thoughts from a Forest Researcher. Journal of Forestry. 89(10). 56–56.
10.
Hubbard, John W., et al.. (1991). Extensive and enantioselective presystemic metabolism of dl-threo-methylphenidate in humans. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 15(2). 213–220. 32 indexed citations
11.
Srinivas, Nuggehally R., John W. Hubbard, & Kamal K. Midha. (1990). Enantioselective gas chromatographic assay with electron-capture detection for dl-ritalinic acid in plasma. Journal of Chromatography B Biomedical Sciences and Applications. 530(2). 327–336. 21 indexed citations
12.
Shu, Yue‐Zhong, et al.. (1990). Identification of phenolic doxepin glucuronides from patient urine and rat bile.. Drug Metabolism and Disposition. 18(6). 1096–1099. 8 indexed citations
13.
Chakraborty, Bhaswat S., John W. Hubbard, E. M. Hawes, et al.. (1989). Interconversion between haloperidol and reduced haloperidol in healthy volunteers. European Journal of Clinical Pharmacology. 37(1). 45–48. 32 indexed citations
14.
Hubbard, John W., Nuggehally R. Srinivas, Declan Quinn, & Kamal K. Midha. (1989). Enantioselective Aspects of the Disposition of dl-threo-Methylphenidate after the Administration of a Sustained-Release Formulation to Children with Attention Deficit-Hyperactivity Disorder. Journal of Pharmaceutical Sciences. 78(11). 944–947. 47 indexed citations
15.
Marshall, Barringer D., Shirley M. Glynn, Kamal K. Midha, et al.. (1989). Adverse Effects of Fenfluramine in Treatment Refractory Schizophrenia. Journal of Clinical Psychopharmacology. 9(2). 110–115. 19 indexed citations
16.
Srinivas, Nuggehally R., John W. Hubbard, J.K. Cooper, & K.K. Midha. (1988). Enantioselective gas chromatographic assay with electron-capture detection for dl-fenfluramine and dl-norfenfluramine in plasma. Journal of Chromatography B Biomedical Sciences and Applications. 433. 105–117. 13 indexed citations
17.
Chakraborty, Bhaswat S., E. M. Hawes, G. McKay, et al.. (1988). S-OXIDATION OF THIORIDAZINE TO PSYCHOACTIVE METABOLITES: AN ORAL DOSE-PROPORTIONALITY STUDY IN HEALTHY VOLUNTEERS. Drug metabolism and drug interactions. 6(3-4). 425–438. 3 indexed citations
18.
Midha, Kamal K., et al.. (1988). Radioimmunoassay for fluphenazine sulfoxide in human plasma. Journal of Pharmacological Methods. 19(1). 63–74. 4 indexed citations
19.
Hubbard, John W., Keith Bailey, K.K. Midha, & James K. Cooper. (1981). 3-O-methyl-alpha-methyldopamine, a urinary metabolite of p-methoxyamphetamine in dog and monkey.. Drug Metabolism and Disposition. 9(3). 250–254. 5 indexed citations
20.
Hubbard, John W., et al.. (1978). alpha-Methyldopamine, a key intermediate in the metabolic disposition of 3,4-methylenedioxyamphetamine in vivo in dog and monkey.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 6(6). 623–30. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen H. Curry Breakdown of academic impact, for papers by Sebastian Härtter Breakdown of academic impact, for papers by Sheila Dawling Breakdown of academic impact, for papers by Lars F. Gram Breakdown of academic impact, for papers by P. L. Morselli Breakdown of academic impact, for papers by Marcia Divoll Breakdown of academic impact, for papers by D J Greenblatt Breakdown of academic impact, for papers by Roberto Goméni Breakdown of academic impact, for papers by Joseph C. Fleishaker Breakdown of academic impact, for papers by Iain M. McIntyre
Rankless by CCL
2026